{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:08:45Z","timestamp":1794956925708,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.semarthrit.2024.152366","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T23:56:37Z","timestamp":1705794997000},"page":"152366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD)"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0889-9877","authenticated-orcid":false,"given":"Cristiana","family":"Sieiro Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Calleja","family":"Antol\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier De la Calle","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L\u00f3pez","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Moriano","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Bollo","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Retuerto","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Sierra","family":"Herr\u00e1nz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira D\u00edez","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2024.152366_bib0001","first-page":"81","article-title":"Relationshipbetween cutaneous and pulmonary involvement in systemic scle-rosis","volume":"24","author":"Morelli","year":"1997","journal-title":"J. Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0002","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10067-017-3936-7","article-title":"First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study","volume":"37","author":"Rubio-Rivas","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152366_bib0003","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.12-0741","article-title":"Diagnosis and treatment of connective tissue disease-associated interstitial lung disease","volume":"143","author":"Vij","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0004","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.38702","article-title":"Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?","volume":"66","author":"Herzog","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1148\/radiol.2322031223","article-title":"CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia","volume":"232","author":"Desai","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0006","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1136\/annrheumdis-2014-205637","article-title":"Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study","volume":"73","author":"Frauenfelder","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0007","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3899\/jrheum.080633","article-title":"Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma","volume":"36","author":"Hant","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0008","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","article-title":"KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease","volume":"148","author":"Kohno","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0009","first-page":"66","article-title":"Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review","volume":"65","author":"Tan","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0010","article-title":"Circulating biomarkers of interstitial lung disease in systemic sclerosis","volume":"2012","author":"Lota","year":"2012","journal-title":"Int J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2024.152366_bib0011","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/03009742.2018.1477989","article-title":"Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study","volume":"48","author":"Matsuo","year":"2019","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152366_bib0012","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5606\/ArchRheumatol.2017.6175","article-title":"Serum Interleukin-18 level is associated with disease activity and interstitial lung disease in patients with dermatomyositis","volume":"32","author":"Yang","year":"2017","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0013","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung dis-ease","volume":"380","author":"Distler","year":"2019","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0014","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3899\/jrheum.151322","article-title":"An open-label,phase II study of the safety and tolerability of pirfenidone inpatients with scleroderma-associated interstitial lung disease: theLOTUSS trial","volume":"43","author":"Khanna","year":"2016","journal-title":"J. Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152366_bib0015","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1165\/rcmb.2003-0078OC","article-title":"Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts","volume":"29","author":"Atamas","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0016","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5","article-title":"Clinical signifi cance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis","volume":"44","author":"Asano","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0017","first-page":"930","article-title":"Serum levels of KL-6 as a useful marker for evaluating pulmonary fi brosis in patients with systemic sclerosis","volume":"27","author":"Yamane","year":"2000","journal-title":"J Rheumatol J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0018","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.21257","article-title":"Serum pulmonary and activation-regulated chemokine\/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis","volume":"52","author":"Kodera","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0019","first-page":"429","article-title":"Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fi brosis","volume":"21","author":"Yanaba","year":"2003","journal-title":"Clin Exp Rheumatol Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2024.152366_bib0020","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1002\/cti2.1045","article-title":"Analysis of serum interleukin(IL)-1\u03b1, IL-1\u03b2 and IL-18 in patients with systemic sclerosis","volume":"8","author":"Lin","year":"2019","journal-title":"Clin Transl Immunology"},{"issue":"6","key":"10.1016\/j.semarthrit.2024.152366_bib0021","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1165\/rcmb.2003-0306OC","article-title":"Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis","volume":"31","author":"Kitasato","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152366_bib0022","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/jid.2009.302","article-title":"IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway","volume":"130","author":"Kim","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2024.152366_bib0023","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13075-022-02889-5","article-title":"Role of NLRP3 inflammasome in systemic sclerosis","volume":"24","author":"Lin","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"6 Suppl 86","key":"10.1016\/j.semarthrit.2024.152366_bib0024","article-title":"Follow-up of serum KL-6 lung fibrosis biomarker levels in 173 patients with systemic sclerosis","volume":"32","author":"Kum\u00e1novics","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152366_bib0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13075-019-1835-9","article-title":"Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease","volume":"21","author":"Lee","year":"2019","journal-title":"Arthritis Res Ther"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:13:49Z","timestamp":1758734029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":25,"alternative-id":["S0049017224000076"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152366","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD)","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152366"}}